The Quantellect read.As of Nov 19, 2026, 17 active firms cover Healthpeak Properties Inc: 4 rate it Buy or better, 13 sit at Neutral, and 0 rate it Sell or worse, a neutral consensus. Targets span $17.00 to $24.00, a moderate spread. The average target of $21.67 sits 12% above the current $19.33. The rating mix has stayed broadly stable, with Buy-side ratings easing from 5 to 4 over recent months. On the fundamentals, the Street sees consensus EPS building from about $0.03 next quarter toward $0.12 the year after.Descriptive synthesis of third-party analyst data, not a Quantellect rating or recommendation.
ANALYST CONSENSUS17 active firms
Neutral
Strong Buy00%
Buy424%
Neutral1376%
Sell00%
Strong Sell00%
Based on 17 active firms as of Nov 19, 2026 (365-day activity window).
12-MONTH PRICE TARGET
$21.67
+12.1% upside
Average target across 15 active firms as of Nov 19, 2026 vs $19.33 current
Highest Target$24.00
Average Target$21.67
Lowest Target$17.00
Detailed analyst forecasts for DOC
Showing 1–18 of 18 named analysts shown · 17 active firms in the rating projection
As of Nov 19, 2026, 4 of 17 active firms rate DOC a Buy (13 Neutral, 0 Sell). Historical months are month-end active-firm counts; the current month uses its actual as-of date.
DOC EPS & revenue forecast
EPS · NEXT QUARTER
$0.03
Range $0.03 – $0.03 · 1 analysts
Next period, 1 analysts expect Healthpeak Properties Inc to earn $0.03 a share (range $0.03 – $0.03), versus — a year earlier. Full-year consensus is $0.09, growing to $0.12 the year after.
REVENUE · NEXT QUARTER
$786.2M
Range $703.3M – $881.1M · 1 analysts · +6% YoY
Revenue is expected to reach $786.2M (range $703.3M – $881.1M), +6.4% year-over-year. Full-year consensus is $3.1B, rising to $3.2B next year.
Top analysts covering Healthpeak Properties Inc
Ranked by each analyst's overall Quantellect track record across all the stocks they cover, shown with their current call on DOC.
#1
Jonathan Hughes
Raymond James · Rank #42
Buy
$20.00+3.5% to target
Overall win rate
52%
+ Follow
#2
Nicholas Yulico
Scotiabank · Rank #77
Neutral
$21.00+8.6% to target
Overall win rate
53%
+ Follow
#3
John Kilichowski
Wells Fargo · Rank #103
Neutral
No targeton DOC
Overall win rate
50%
+ Follow
#4
Richard Hightower
Barclays · Rank #184
Neutral
$21.00+8.6% to target
Overall win rate
45%
+ Follow
#5
JK
James Kammert
Evercore ISI Group
Neutral
$22.00+13.8% to target
Coverage
—
+ Follow
DOC stock forecast FAQ
What is DOC's average 12-month price target?+
The 15 active firms with a live target average $21.67 for Healthpeak Properties Inc over the next 12 months, ranging from a $24.00 high to a $17.00 low, as of Nov 19, 2026.
Is DOC stock a Buy, Sell or Neutral right now?+
The current consensus is Neutral. Of the 17 active firms as of Nov 19, 2026, 4 rate it Buy or Strong Buy, 13 rate it Neutral, and 0 rate it Sell or Strong Sell.
What are the highest and lowest price targets for DOC?+
The Street-high target is $24.00 (Baird), and the Street-low is $17.00 (Goldman Sachs). The average of all 15 active-firm targets is $21.67.
How many active Wall Street firms cover DOC?+
17 active firms have a recognized rating on Healthpeak Properties Inc as of Nov 19, 2026, and 15 active firms carry a live 12-month price target.
Who is the most accurate analyst covering DOC?+
Among analysts who currently cover DOC, Jonathan Hughes of Raymond James has the strongest overall Quantellect track record (Rank #42). Their current call is Buy with a $20.00 target.
What is Healthpeak Properties Inc's projected EPS for next quarter?+
The consensus estimate is $0.03 per share (range $0.03 – $0.03) across 1 analysts. Full-year EPS is projected at $0.09, rising to $0.12 the following year.
How much revenue is Healthpeak Properties Inc expected to report next quarter?+
Consensus revenue is $786.2M (range $703.3M – $881.1M). Full-year revenue is projected at $3.1B, growing to $3.2B next year.
Have analysts been upgrading or downgrading DOC lately?+
As of Nov 19, 2026, 4 of 17 active firms rate DOC a Buy (13 Neutral, 0 Sell). Historical months are month-end active-firm counts; the current month uses its actual as-of date.
How are the analysts on this page ranked?+
By each analyst's overall Quantellect track record — a sample-adjusted measure of how accurate their calls have been across every stock they cover. We do not rank on their DOC calls alone, since a single stock is too small a sample to be reliable.
Which data on this page is live, and how often does it update?+
Price and daily change are 15-minute delayed market data. Analyst ratings, targets, consensus and earnings estimates are aggregated from multiple data providers and refresh daily.
Disclaimer: Ratings, price targets, consensus and earnings estimates on this page describe third-party analyst research aggregated from multiple data providers and refreshed daily; price and daily change are 15-minute delayed. These are historical opinions, not recommendations, and nothing on this page, including The Quantellect read, is a rating, a price target, or investment advice from Quantellect. Always do your own research and consult a licensed financial advisor before making investment decisions.